CorDx Tyfast at Home Flu A/B and COVID 19 Rapid Test Kit, Easy, Accurate, Fast Results in 10 Minutes. (90-Pack, 180 Tests)

Price: $11.75
(as of Mar 15, 2025 05:11:00 UTC – Details)

From the brand

Shop Flu A/B & Covid-19 Tests

Shop Covid-19 Antigen Test

Shop Family Planning

How did we get our start?

CorDx is at the cutting edge of technology, artificial intelligence, and data science to deliver diagnostic solutions to the most critical questions in healthcare.

What makes our products unique?

The CorDx Tyfast 3-in-1 Flu A/B & COVID-19 At-Home Multiplex Rapid Test is made in the USA. Our diagnostic products embody the highest standards of quality, accessibility, and affordability.

Why Use CorDx Tyfast 3-in-1 Flu A/B & COVID-19 At-Home Multiplex Rapid Test?

5 nostril turns, 1 squeeze & 3 drops give accurate results in 10 minutes for faster, easier, convenient testing.

Package Dimensions ‏ : ‎ 18.5 x 14 x 13.85 inches; 11.65 Pounds
Item model number ‏ : ‎ ACT21002-90
Date First Available ‏ : ‎ July 1, 2024
ASIN ‏ : ‎ B0DB3J328C
Flu-A, Flu-B, & Covid-19 test kit: Designed by Aiiso in San Diego! Focused on eco-friendliness, compact efficiency, usability, broad applicability (including for children & the elderly), and comprehensive testing for three major respiratory illnesses.
Only 5 turns per nostril —why bother with 10? Get quick and reliable results with less effort, making testing easier for the whole family, Our covid & flu test kit for home works for individuals ages 2+.
1 buffer tube squeeze —why require 5x? Insert swab into buffer, stir 10 times, squeeze once, and discard! One squeeze spares your fingers from strain.
3 drops are sufficient —no need for 5! Get more accurate detection with less drops. Test for Flu A, Flu B & COVID-19 all at once, bypassing doctors visits and protecting loved ones from contagious illnesses at school, work, or public gatherings.
10 minute accuracy —why wait 15? With our rapid testing kit, get peace of mind in 10 minutes and precise results without the extra wait. Proven higher PPA than major competitors, based on FDA-IFUs.